Maiden Stock Price, News & Analysis (NASDAQ:MHLD)

Maiden trades on the NASDAQ under the ticker symbol "MHLD."

Maiden Holdings, Ltd. (NASDAQ:MHLD) announced its quarterly earnings data on Monday, August, 12th. The insurance provider reported ($0.27) earnings per share for the quarter, missing analysts' consensus estimates of $0.14 by $0.41. The insurance provider had revenue of $165.86 million for the quarter. Maiden had a negative net margin of 42.41% and a negative return on equity of 308.89%. View Maiden's Earnings History.

Maiden is scheduled to release their next quarterly earnings announcement on Friday, November 8th 2019. View Earnings Estimates for Maiden.

1 brokers have issued 12-month target prices for Maiden's stock. Their predictions range from $1.00 to $1.00. On average, they anticipate Maiden's stock price to reach $1.00 in the next year. This suggests a possible upside of 55.0% from the stock's current price. View Analyst Price Targets for Maiden.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Maiden in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Maiden.

News coverage about MHLD stock has trended negative recently, InfoTrie reports. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Maiden earned a media sentiment score of -2.6 on InfoTrie's scale. They also gave headlines about the insurance provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Maiden.

Maiden saw a drop in short interest in September. As of September 15th, there was short interest totalling 939,800 shares, a drop of 7.9% from the August 15th total of 1,020,000 shares. Based on an average daily volume of 401,700 shares, the short-interest ratio is presently 2.3 days. Approximately 1.7% of the company's stock are sold short. View Maiden's Current Options Chain.

Some companies that are related to Maiden include Federated National (FNHC), Kingstone Companies (KINS), Blue Capital Reinsurance (BCRH), Kingsway Financial Services (KFS), ICC (ICCH), Conifer (CNFR), Unico American (UNAM), 1347 Property Insurance (PIH), Oxbridge Re (OXBR), Atlas Financial (AFH), Baldwin & Lyons Inc Class B (BWINB) and Till Capital (TIL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Maiden investors own include AmTrust Financial Services (AFSI), Ford Motor (F), Medical Properties Trust (MPW), New Residential Investment (NRZ), Catalyst Pharmaceuticals (CPRX), Centurylink (CTL), General Electric (GE), Teekay Lng Partners (TGP), Oncolytics Biotech (ONCYF) and Advanced Micro Devices (AMD).

Shares of MHLD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MHLD stock can currently be purchased for approximately $0.65.

Maiden has a market capitalization of $53.56 million and generates $2.16 billion in revenue each year. Maiden employs 74 workers across the globe.View Additional Information About Maiden.

The official website for Maiden is http://www.maiden.bm/.

Maiden's mailing address is 94 Pitts Bay Road, Pembroke D0, HM 08. The insurance provider can be reached via phone at 441-298-4900 or via email at [email protected]